GLADSTONE AIREWELE to Anemia, Sickle Cell
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Anemia, Sickle Cell.
Connection Strength
2.985
-
Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola. Pediatr Blood Cancer. 2018 12; 65(12):e27365.
Score: 0.466
-
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol. 2011 Apr; 153(1):92-104.
Score: 0.279
-
Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer. 2009 Dec; 53(6):1060-3.
Score: 0.256
-
A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection. Lab Chip. 2024 08 20; 24(17):4115-4127.
Score: 0.178
-
Hospital acquired venous thromboembolism in children with sickle cell disease. Pediatr Hematol Oncol. 2024 Oct; 41(7):459-469.
Score: 0.175
-
Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Pediatr Blood Cancer. 2014 Jun; 61(6):1049-54.
Score: 0.171
-
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538.
Score: 0.166
-
Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States. Sci Rep. 2023 04 25; 13(1):6758.
Score: 0.162
-
Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings. Anal Chem. 2021 03 23; 93(11):4832-4840.
Score: 0.140
-
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
Score: 0.133
-
Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics. 2010 Jul; 126(1):53-61.
Score: 0.133
-
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL? Sickle Cell Disease Module. Health Qual Life Outcomes. 2017 Jun 12; 15(1):124.
Score: 0.108
-
A Paper-Based Test for Screening Newborns for Sickle Cell Disease. Sci Rep. 2017 04 03; 7:45488.
Score: 0.106
-
A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola. J Pediatr. 2015 Dec; 167(6):1314-9.
Score: 0.096
-
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015 Oct 01; 126(14):1651-7.
Score: 0.095
-
Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am J Hematol. 2015 Jan; 90(1):2-7.
Score: 0.090
-
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014 Aug 21; 371(8):699-710.
Score: 0.089
-
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood. 2012 Apr 19; 119(16):3684-90.
Score: 0.073
-
Improving care for children with sickle cell disease/acute chest syndrome. Pediatrics. 2011 Feb; 127(2):e480-8.
Score: 0.069